183 related articles for article (PubMed ID: 17448952)
1. Risk assessment in haematopoietic stem cell transplantation.
Gratwohl A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):119-24. PubMed ID: 17448952
[No Abstract] [Full Text] [Related]
2. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia.
Weisdorf D; Forman S
Cancer Treat Res; 2009; 144():441-54. PubMed ID: 19779879
[No Abstract] [Full Text] [Related]
4. [Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation for 8 patients with leukemia and review of the literature].
Xie XS; Wan DM; Sun H
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):636-7. PubMed ID: 21122422
[No Abstract] [Full Text] [Related]
5. [Autologous graft of hematopoietic stem cells. Current and perspective strategies].
Hervé P
Rev Prat; 1991 Oct; 41(21):2072-7. PubMed ID: 1686122
[TBL] [Abstract][Full Text] [Related]
6. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies.
Lassaletta A; Ramírez M; Montero JM; González-Vicent M; Balas A; Madero L; Díaz MA
Leukemia; 2005 Apr; 19(4):504-6. PubMed ID: 15729381
[No Abstract] [Full Text] [Related]
7. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia].
Tomás JF; Fernández-Rañada JM
Sangre (Barc); 1998 Apr; 43(2):147-54. PubMed ID: 9656776
[No Abstract] [Full Text] [Related]
9. [Allogeneic umbilical cord blood transplantation in overweight patients: evaluation of outcome, alloreactivity and morbidity. Preliminary results of a phase I study].
Romero R; Cabrera R; Regidor C; Sanjuán I; Forés R; Briz M; Steegmann JL; Bañas H; Fernández MN
Sangre (Barc); 1997 Apr; 42(2):123-33. PubMed ID: 9297260
[No Abstract] [Full Text] [Related]
10. Demodicidosis as a cause of facial eruption developing early after allogeneic hematopoietic stem cell transplantation.
Aisa Y; Mori T; Tanikawa A; Takae Y; Kato J; Ikeda Y; Okamoto S
Transpl Int; 2008 Dec; 21(12):1192-3. PubMed ID: 18783387
[No Abstract] [Full Text] [Related]
11. Current thinking in the management of leukaemia.
Szer J
Aust Fam Physician; 1994 Aug; 23(8):1500-5. PubMed ID: 7526835
[TBL] [Abstract][Full Text] [Related]
12. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia.
Athanasiadou A; Stamatopoulos K; Sakellari I; Zorbas I; Gaitatzi M; Fassas A; Anagnostopoulos A
Bone Marrow Transplant; 2004 Jul; 34(2):189-91. PubMed ID: 15156167
[No Abstract] [Full Text] [Related]
13. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
14. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
15. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
[TBL] [Abstract][Full Text] [Related]
16. [Acute myeloid leukemia].
Bol P
Ned Tijdschr Tandheelkd; 2002 Nov; 109(11):463-4. PubMed ID: 12494710
[No Abstract] [Full Text] [Related]
17. Current status of vaccination therapy for leukemias.
Reichardt VL; Brossart P
Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
19. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
20. Current world literature.
Curr Opin Hematol; 2011 Mar; 18(2):124-31. PubMed ID: 21307671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
